Skip to content

Phage-Assisted Continuous Selection of Bioactive Cyclic Peptides.

2026 · Methods in molecular biology · Vol 3032, pp. 199-219 · 0 citations
Medicine

TL;DR

A comprehensive protocol for applying phage-assisted continuous evolution (PACE) strategy to select CP inhibitors against aggregation-prone proteins of interest is provided.

View source

Similar papers

Review Open access Sep 2026

De Novo Discovery of Bioactive Cyclic Peptides via Cellular Selection of Genetically Encoded Libraries

Cellular selection has emerged as a powerful approach for high throughput de novo discovery of bioactive cyclic peptides (CPs). This strategy coexpresses genetically encoded CP libraries with the target of interest in cells and uses customizable selection systems to link desired CP activities to a selectable phenotype...

Lin-Wei Yang, Abhijit Behera, Hannah J. Meyers et al. · 0 citations
Review Open access Sep 2026

Architectural Design of Phage-Displayed Peptide Libraries for Peptide Discovery.

Peptide phage display is a cornerstone technology in molecular engineering, providing a robust platform for the rapid discovery of high-affinity ligands. The rapid rise of peptides, especially in therapeutics, over recent years has shed light on the importance of phage display as a tool for peptide discovery. The evolu...

Belle Li Ling, Huan Peng, T. S. Lim · 0 citations
Open access Aug 2026

Bacterial Display of Genetically Encoded Macrocyclic Peptide Libraries Using Cysteine-Reactive Unnatural Amino Acids

Cyclic peptides are powerful scaffolds for modulating protein–protein interactions; however, methods for constructing cyclic peptide libraries for cell-surface display applications remain limited. Here, we present a bacterial surface display platform that enables site-specific incorporation of diverse unnatural amino...

Olabode Dawodu, Jeffery M Tharp · 0 citations
Open access Sep 2026

Sortase-mediated generation of various macrocyclic peptide scaffolds from low-reactivity electrophilic substrates

Macrocyclic peptides possess numerous advantages, including enhanced tissue penetration, low immunogenicity, good resistance to protease degradation, and high targeting specificity, making them increasingly attractive for drug development. Genetically encoded cyclic peptide libraries enable rapid and convenient de novo...

Zhe-Min Xia, Hui-Min Wei, Jun-Hao Xue et al. · 0 citations
Open access Sep 2026

Peptide ligands targeting GP64 for the purification of Baculovirus from insect cell lysates.

The first peptide affinity ligands targeting the baculoviral envelope glycoprotein GP64 for the purification of active Baculovirus particles are introduced, establishing SB4-POROS as a promising technology with a favorable projected cost structure for Baculovirus purification.

Will Smith, S. Sripada, Yuxuan Wu et al. · 0 citations
Review Open access Sep 2026

Anticancer Peptides: Design Principles, Translational Bottlenecks, and Emerging Opportunities

Anticancer peptides (ACPs) are frequently discussed as a single therapeutic class, yet the term encompasses molecules that perform markedly different jobs: direct tumor-cell killing, intracellular target modulation, tumor homing and penetration, or selective delivery of a separate payload. This functional diversity cre...

Marissa E. Di, Y. Di · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.